Maciej Wieczorek on the strategies of developing innovative medicines at the 11th Multiciplinary conference on pharmaeutical science “Science for the Industry, Industry for science”
2018-11-13 | News
On 16 November this year, President of the Management Board of Celon Pharma S.A. will give a lecture discussing the discovery and implementation of innovations in the pharmaceutical sector on the example of drug candidates developed under Celon Pharma’s clinical programmes. He will also participate in an expert debate entitled: “Business for science”. We encourageRead more »
Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.
Aleksandra Stańczak, PhD, Leader of the Oncology Research Group will present results for two inhibitors under Celon Pharma’s development at the 30th symposium organised by European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR), to be held on 13-16. November in Dublin. The followingRead more »
Celon Pharma at WSE
People are the key to the success of all projects. We know this well and we would also like you to learn this first hand. As a Celon Pharma S.A. employee, you will be provided with an attractive salary, in-depth training and an incentive system. What is equally important, you will have the satisfaction of working with modern and essential drugs which save and extend human life.